Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Over 170 Provisional Draft Codes Published For Notified Body Designation Under MDR & IVDR

Executive Summary

Three new draft documents relating to notified bodies list the codes being prepared to determine their scope of responsibility for designation under the new EU medtech regulations and the raft of documentation they will be asked to submit when they apply for redesignation.

You may also be interested in...



EU Commission Issues A Last-Minute Implementing Regulation For Notified Bodies

Some 20 notified bodies were due to apply for designation under the EU's new Medical Device and IVD Regulations on November 26, and more after. The European Commission published needed codes for the process just one day before the application process began. Could that have created a hold up?

Notified Bodies Apply For EU MDR/IVDR Designations Despite Document Shortfall

If there is a delay in appointing EU notified bodies under the new Medical Device and IVD Regulations, it will impact the whole sector's ability to comply in time. But nothing is quite ready.

Global Medtech Guidance Tracker: August 2017

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirteen new guidance documents were posted to the tracker in August.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT105299

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel